Bernard Fox/X
Apr 26, 2025, 05:17
Bernard A. Fox: Heading to AACR2025 to talk about our work on cancer immunotherapy for HNSCC
Bernard A. Fox, Co-Founder / President / CEO at UbiVac, posted on X:
“Heading to AACR2025 in Chicago to talk about our work on combination cancer immunotherapy for HNSCC and see what is exciting scientists from across the globe.
Also looking forward to visiting the Loyola University Chicago Cancer Center to talk with Prof. Michael Nishimura regarding TCR.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49